Bayer boosts sales 4.1% to €13B in Q1

Thursday, 25. April 2019 07:38

Bayer AG said on Thursday that its sales in the first quarter of 2019 amounted to €13.01 billion, which is 4.1% higher than the year before, adjusted for foreign exchange rates and portfolio. The biggest increase was recorded in North America, up by 96.3%, followed by Latin America's jump of 78.3%.

Earnings per share (EPS) from continuing and discontinued operations dove 42.5% to €1.27, while EPS from continuing operations improved 13.8% to arrive at €2.55, the financial report showed.

The pharmaceutical company had earnings before interest, taxes, depreciation, and amortization (EBITDA) of €3.14 billion, marking an increase of 11.4% year over year in the first three months of this year. Meanwhile, net income from continuing and discontinued operations fell 36.5% to €1.24 billion in the quarter, as the headcount rose 16.3% to 116,428 employees.

Bayer confirmed the outlook for this year first published in its 2018 Annual Report.

Related Links: Bayer AG
Author:
Breaking the News / NI